Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | Why Mutational Status in mNSCLC Matters | Know Before |
Description | DON’T FORCE FIT FIRST-LINE Learn why confirming mutational status matters and why immunotherapy is not a guideline-recommended first-line choice for patients with mNSCLC and certain actionable |
Keywords | N/A |
WebSite | knowbeforeio.com |
Host IP | 52.85.47.114 |
Location | United States |
Site | Rank |
US$270,801
Last updated: 2023-05-17 07:09:33
knowbeforeio.com has Semrush global rank of 39,085,299. knowbeforeio.com has an estimated worth of US$ 270,801, based on its estimated Ads revenue. knowbeforeio.com receives approximately 31,247 unique visitors each day. Its web server is located in United States, with IP address 52.85.47.114. According to SiteAdvisor, knowbeforeio.com is safe to visit. |
Purchase/Sale Value | US$270,801 |
Daily Ads Revenue | US$250 |
Monthly Ads Revenue | US$7,500 |
Yearly Ads Revenue | US$89,989 |
Daily Unique Visitors | 2,084 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
knowbeforeio.com. | A | 60 | IP: 52.85.47.114 |
knowbeforeio.com. | A | 60 | IP: 52.85.47.81 |
knowbeforeio.com. | A | 60 | IP: 52.85.47.42 |
knowbeforeio.com. | A | 60 | IP: 52.85.47.64 |
knowbeforeio.com. | NS | 21600 | NS Record: ns-1229.awsdns-25.org. |
knowbeforeio.com. | NS | 21600 | NS Record: ns-154.awsdns-19.com. |
knowbeforeio.com. | NS | 21600 | NS Record: ns-1775.awsdns-29.co.uk. |
knowbeforeio.com. | NS | 21600 | NS Record: ns-979.awsdns-58.net. |
Toggle navigation Medicines Medicines Home DON’T FORCE FIT IS 1L IO OPTIMAL? WHY TARGETED THERAPY? IT’S UP TO YOU More Hide IN PATIENTS WITH METASTATIC NSCLC AND CERTAIN ACTIONABLE MUTATIONS DON’T FORCE FIT FIRST-LINE IO Sequential IO followed by TKI treatment could harm patients with mNSCLC and certain actionable mutations 1-7 * LEARN MORE ABOUT HOW YOU CAN HELP AVOID THE RISK OF INCREASED TOXICITY ASSOCIATED WITH IMMUNOTHERAPY FOLLOWED BY A TKI IN CERTAIN PATIENTS 1-7 * *Based on 6 studies of 3867 patients with NSCLC and EGFR sensitizing mutations, and 1 study including 345 patients with NSCLC and ALK mutations. Of the 3867 patients with EGFR mutations, 395 were treated with immunotherapy followed by EGFR TKIs. Of the 345 patients with ALK mutations, 3 were treated with immunotherapy followed by an ALK TKI. Adverse reactions, including ILD, were observed following the sequential use of IO followed by TKI therapy in patients who had actionable mutations. 1-7 IN PATIENTS WITH mNSCLC |
HTTP/1.1 301 Moved Permanently Content-Type: text/html; charset=iso-8859-1 Connection: keep-alive Cache-Control: no-cache="set-cookie" Date: Fri, 11 Mar 2022 09:26:29 GMT Location: https://www.knowbeforeio.com/ Server: Apache Set-Cookie: AWSELB=EBF761C41AEC7A5A642D98AC2D175D7ABA787EC682199649F6B66871813EE55CC5A779E73CCCD590B03850720DDF23F59700CCCCA9185157FF1DC297766A1E8A4D8DC13D;PATH=/;MAX-AGE=7200 X-Cache: Miss from cloudfront Via: 1.1 dde62003552e800310ee1980113eedb4.cloudfront.net (CloudFront) X-Amz-Cf-Pop: HEL50-C2 X-Amz-Cf-Id: 02HQ0G_doJVgSdsjuqcAVgJLmEy-cNyUWl0qbKaEkpW1muXsGigSag== HTTP/2 200 content-type: text/html;charset=utf-8 cache-control: max-age=0, no-cache cache-control: no-cache="set-cookie" date: Fri, 11 Mar 2022 09:26:30 GMT server: Apache set-cookie: AWSELB=EBF761C41AEC7A5A642D98AC2D175D7ABA787EC6F51CD74F77E42270EA12537098530E69CD36D11A01546AB1EA3E8126EFA642072ACD7E511F59F566CC79410E28724765;PATH=/;MAX-AGE=7200 set-cookie: AWSELBCORS=EBF761C41AEC7A5A642D98AC2D175D7ABA787EC6F51CD74F77E42270EA12537098530E69CD36D11A01546AB1EA3E8126EFA642072ACD7E511F59F566CC79410E28724765;PATH=/;MAX-AGE=7200;SECURE;SAMESITE=None vary: User-Agent x-cache: Miss from cloudfront via: 1.1 88944815e9efa1cfbf5b6acdd146175a.cloudfront.net (CloudFront) x-amz-cf-pop: HEL50-C2 x-amz-cf-id: Z-KbdVPw3gsVvzrWyb9togtpjeeEw8RdC4H9MKuxmt8zL0lHwNXytA== |
Domain Name: KNOWBEFOREIO.COM Registry Domain ID: 2629501489_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-11-22T16:08:15Z Creation Date: 2021-07-26T18:56:07Z Registry Expiry Date: 2022-07-26T18:56:07Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1229.AWSDNS-25.ORG Name Server: NS-154.AWSDNS-19.COM Name Server: NS-1775.AWSDNS-29.CO.UK Name Server: NS-979.AWSDNS-58.NET DNSSEC: unsigned >>> Last update of whois database: 2022-03-11T09:58:16Z <<< |